The Synthetic Biology Innovation Network

Biopharma

Biopharma

Editors' picks

COP26 in Review: It’s a Race Against the Clock

We at SynBioBeta watched with excitement as almost 200 countries met in Glasgow, Scotland, earlier this month for the United Nations Climate Change Summit (COP26). As leaders gathered to discuss taking urgent action to...

How Science Will Actually Solve Climate Change

2Q 2021 Synthetic Biology Venture Investment Report

The second quarter of 2021 was another record-breaking period for the synthetic biology startup community. Building on the extremely high amount of investment we saw in Q1 ($4.7 billion), Q2 also brought in more than $4...

SynBioBeta 2021 is Pushing to January 25-27, 2022

Letter From the Editor: Leading the Future Is Never Easy

Investors Bet Big with Fungi Alternative Protein Company Enough

In the race to make alternative meat mainstream, it’s less a question of if it will happen, but how. Earlier this year, a report by the Boston Consulting Group and Blue Horizon Corporation predicted that regular meat...

Is Tissue Engineering The Future of Cruelty-Free Fashion?

So You Want to Sell Your Genome As an NFT? Read This First

In the past few months, non-fungible tokens, or NFTs, have become the hot new investment trend, generating skepticism, confusion, and millions of dollars. Jack Dorsey, the founder and CEO of Twitter, auctioned off his...

The Search for a Cancer Vaccine: Have We Been Doing It All Wrong?

Can Microbes Clean The World’s Most Polluted Waterways?

View all posts

Press releases

Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System

Proven CleanCap® reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applications Codex DNA scientists to share latest data and showcase mRNA...

EnginZyme joins forces with leading food processing company to improve food & beverage production

STOCKHOLM, Nov. 29, 2021 /PRNewswire/ — EnginZyme, a leading developer of cell-free biomanufacturing processes, today announced that the company has signed a joint development agreement with a global processing...

Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits

San Diego, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, and RNAimmune, a leading biotech company with expertise in messenger RNA...

Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs

November 18, 2021 08:00 AM Eastern Standard Time SOUTH SAN FRANCISCO, Calif. & BOSTON–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its...

Antheia Appoints Zack McGahey as Chief Operating Officer

Company appoints leading biomanufacturing operations executive as COO to drive transition to commercial scale manufacturing MENLO PARK, Calif., Nov. 18, 2021 /PRNewswire/ — Antheia, a synthetic biology company...

mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities

MELBOURNE, Australia and BOSTON, Nov. 17, 2021 /PRNewswire/ — mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State’s mRNA manufacturing and research...

Sofinnova Partners Raises €150M for Its Third Industrial Biotech Fund Dedicated to Environmental Impact

The fund will invest in companies leveraging biotechnology to develop sustainable solutions Sofinnova Industrial Biotech II is part of the VC firm’s pioneering strategy initiated over a decade ago November 17, 2021...

CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes

-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused...

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights November 16, 2021 04:30 AM...

Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026

EMERYVILLE, Calif., Nov. 15, 2021 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating...

Roswell Biotechnologies Unveils First Molecular Electronics Chip to Digitize Biology

Company kicks off early development partnership program for the Roswell Molecular Electronics Platform in drug discovery, molecular diagnostics, and sequencing SAN DIEGO, Nov. 15, 2021 /PRNewswire/ — Roswell...

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases

— Executive Leadership Team Established with Demonstrated Success in Clinical, Regulatory and Commercial Development — November 15, 2021 08:00 AM Eastern Standard Time SOUTH SAN FRANCISCO, Calif...